By creator to finance.yahoo.com
Newly Shaped Medical Advisory Board to Present Steering on Use of C-Bond Nano-Merchandise within the Struggle Towards COVID-19 and Different Pathogens
HOUSTON, April 13, 2020 (GLOBE NEWSWIRE) — C-Bond Systems, Inc. (the “Firm” or “C-Bond”) (CBNT), a nanotechnology options firm, in the present day introduced the formation of a Medical Advisory Board to advance the breadth and use of merchandise provided by C-Bond Security Options Group, primarily its C-Bond FN Nano® Coating, which is utilized in hospitals and different services to cut back the unfold of pathogens together with COVID-19.
The founding members of the Medical Advisory Board embody Sergio Moreira, Jr., M.D., and Anil Vaidya, M.D., each acknowledged world specialists of their respective fields.
Dr. Moreira is a Diplomate of the American Board of Urology and a member of the Brazilian Medical Affiliation and Brazilian Urologic Society. He’s additionally a Lieutenant Colonel within the U.S. Military Reserves. He has acquired quite a few awards and scholarships all through his profession and is a member of a number of skilled societies together with Particular Operations Medical Affiliation and the American Urological Affiliation, amongst others. Dr. Moreira is extensively printed and a frequent visitor lecturer.
Dr. Vaidya is a multi-organ transplant surgeon with a diversified scientific, translational and educational portfolio. After completion of his surgical/urological residency, Dr. Vaidya went on to undertake an American Society of Transplant Surgeons (ASTS) accredited fellowship in multi-organ transplantation on the College of Miami. He’s a Fellow of the Royal Faculty of Surgeons, England-Transplant Surgical procedure, and the Co-director of the Intestinal Transplant Service at The Cleveland Clinic, Ohio. Dr. Vaidya has authored greater than 120 articles in peer-reviewed journals and his score by Analysis Gate places him among the many high 3% of the surgeons on the planet.
“We’re proud to welcome trusted specialists Dr. Moreira and Dr. Vaidya to our newly shaped Medical Advisory Board, serving to to unfold consciousness and use of the FN-NANO protecting coating, and to depend on their experience and recommendation as we glance to doubtlessly additional broaden our pipeline of nano-products into the healthcare trade,” mentioned Scott R. Silverman, Chairman and Chief Government Officer of C-Bond. “Their collective expertise, relationships and networks are second to none – we strongly imagine they are going to be invaluable property to C-Bond as we develop using these essential security options in hospitals and different services.”
About C-Bond Methods
C-Bond Methods, Inc. (CBNT) is a Houston-based superior nanotechnology firm and marketer of the patented C-Bond know-how, developed together with Rice College and independently confirmed to considerably strengthen glass in key automotive and structural purposes. The Firm’s Transportation Options Group sells C-Bond NanoShield®, a liquid resolution utilized on to automotive windshields, offered via distributors. The Firm’s Security Options Group sells ballistic-resistant glass options and FN NANO Coating instantly to personal enterprises, faculties, hospitals and authorities businesses. For extra info, please go to our web site: www.cbondsystems.com, Fb: https://www.facebook.com/cbondsys/ and Twitter: https://twitter.com/CBond_Systems.
Ahead-Trying Statements
Statements on this press launch about our future expectations, together with the probability that the Medical Advisory Board will assist advance the breadth and use of our merchandise together with FN Nano® Coating to fight the unfold of COVID-19 and different pathogens; the probability that we are going to additional broaden our pipeline of nano-products within the healthcare trade; the probability that Drs. Moreira and Vaidya might be invaluable property to C-Bond as we develop using these essential security options in hospitals and different services; represent “forward-looking statements” inside the which means of Part 27A of the Securities Act of 1933, Part 21E of the Securities Alternate Act of 1934, and as that time period is outlined within the Personal Litigation Reform Act of 1995. Such forward-looking statements contain dangers and uncertainties and are topic to vary at any time, and our precise outcomes may differ materially from anticipated outcomes. These dangers and uncertainties embody, with out limitation, C-Bond’s capability to boost capital; the Firm’s capability to efficiently commercialize its merchandise; in addition to different dangers. Extra details about these and different elements could also be described within the Firm’s filings with the Securities and Alternate Fee (“SEC”) together with its Kind 10-Okay filed on March 25, 2020, its Kinds 10-Q filed on November 14, 2019, August 12, 2019, and Might 10, 2019, and in future filings with the SEC. The Firm undertakes no obligation to replace or launch any revisions to those forward-looking statements to replicate occasions or circumstances after the date of this assertion or to replicate the prevalence of unanticipated occasions, besides as required by legislation.
Investor Contacts:
Luke Zimmerman
Senior Vice President
MZ Group – MZ North America
949-259-4987
CBNT@mzgroup.us
www.mzgroup.us
Allison Tomek
VP, Company Communications
C-Bond Methods, Inc.
atomek@cbondsystems.com
832-649-5658
— to finance.yahoo.com
